The DOI matches its Crossref record; 556 of the 558 references it cites were found in a registry or an index.
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Open accessAbstract
Patients with atrial fibrillation and coronary artery disease . . . . . . . . .1647 Cardioversion in a NOAC-treated patient . . . . . . . . . . . . . . . . . . . . . . . .1651 AF patients presenting with acute stroke while on NOACs . . . . . . . .1652 NOACs in advanced age and frailty . . . . . . . . . . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such switch is very common in the hospital setting, mostly as part of periprocedural bridging [24].”
From Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey (2022) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Self-citationHindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Self-citationIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citationRivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K. J., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B. L., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,957
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Research works printed but not linked: 2
- Corbalan, 2017, [Features, management and prognosis of Chilean patients with non valvular atrial fibrillation: GARFIELD AF registry], Rev Med Chil, 145, 963
- Kubitza, 2006, No interaction between the novel, oral direct factor Xa inhibitor BAY 59-7939 and digoxin, J Clin Pharmacol, 46, 702
Cited by
Sorted by citations
Items 801–900 of 1,000
Perkutaner Vorhofohrverschluss nach Schlaganfall
Skurk, C., Häusler, K. G., Endres, M., Lewalter, T., & Landmesser, U. (2022) · Nervenheilkunde · doi:10.1055/a-1814-2536 · Cited by 1
Liu, F., Zhang, Y., Luo, J., & Zhou, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.813419 · Cited by 1
Adukauskaitė, A., & Stuehlinger, M. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00913-4 · Cited by 2
Antithrombotic management in patients undergoing cardiac implantable electronic device implantation
Mežnar, A. Z., Alatic, J., Kšela, J., Miklič, M., Jan, M., Naji, F. H., Vokač, D., & Žižek, D. (2023) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3402 · Cited by 1
Steffel, J., Ruff, C. T., Antman, E. M., D, E. B. M., & Giugliano, R. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.066 · Cited by 1
Self-citationSteffel, J., & Heidbüchel, H. (2021) · EP Europace · doi:10.1093/europace/euab220 · Cited by 1
Self-citationNew Paradigms in Antithrombotic Strategies: A Leap into the Future of Cardiovascular Medicine
Romiti, G. F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102693 · Cited by 1
Direct oral anticoagulant care Focus on management and monitoring
Gulpen, A. J. W. (2022) · doi:10.26481/dis.20220909ag · Cited by 1
Kardiale, perioperative Risikobeurteilung
Klein, K., & Kelm, M. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62939-0_45-1 · Cited by 1
Vincentis, A. D., Soraci, L., Arena, E., Sciacqua, A., Armentaro, G., Aucella, F., Corsonello, A., Aucella, F., & Incalzi, R. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3286346/v1 · Cited by 1
Testa, S., Palareti, G., Legnani, C., Dellanoce, C., Cini, M., Paoletti, O., Ciampa, A., Antonucci, E., Poli, D., Morandini, R., et al. (2023) · medRxiv · doi:10.1101/2023.12.08.23299746 · Cited by 1
Consultative haemostasis and thrombosis
Laffan, M., & MacCallum, P. (2025) · doi:10.1002/9781119706687.ch57 · Cited by 1
Leitfaden zur sicheren und effizienten Kryoballon-Vorhofflimmerablation
Chun, K. R. J., Maurer, T., Rillig, A., Bordignon, S., Iden, L., Busch, S., Steven, D., Tilz, R. R., Shin, D., Estner, H., et al. (2021) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00820-0 · Cited by 1
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
Rubboli, A., & Atar, D. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.05.009
Self-citationDaei, M., Khalili, H., & Heidari, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-579040/v1
Capiau, A., Grymonprez, M., Backer, T. L. M. D., Gevaert, S., Boussery, K., & Lahousse, L. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.107
Direct oral anticoagulants for electrical cardioversion
Volovchenko, A. N., Andreev, D. A., & Фератовна, М. Д. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2939
Medications that interact with direct-acting oral anticoagulant exposure
de Vries, T. A. C., & de Groot, J. R. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01617-z
Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
Serova, M. V., Andreev, D. A., Chashkina, M. I., & Salpagarova, Z. K. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2974
Li, H., Zhang, L., Xia, M. X., Zhang, C., & Jiang, T. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211044722
Edoxabán: de los ensayos clínicos a la evidencia de la vida real
Vivas, D., Gómez-Polo, J. C., & Vilacosta, I. (2021) · REC CardioClinics · doi:10.1016/j.rccl.2021.09.005
Pía-Morandeira, A., Cinza‐Sanjurjo, S., & Portela‐Romero, M. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.09.012
Chun, K. R. J., Maurer, T., Rillig, A., Bordignon, S., Iden, L., Busch, S., Steven, D., Tilz, R. R., Shin, D., Estner, H., et al. (2021) · Herzschrittmachertherapie + Elektrophysiologie
Cerezo-Manchado, J. J., & Hernández, T. I. (2021) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2021.14.00531
Kovaleva, A. Y., Лукинов, В. Л., & Израйлевна, Л. Г. (2022) · Kardiologiia · doi:10.18087/cardio.2022.1.n1904
Use of Rivaroxaban in Obese Patient With Pulmonary Thromboembolism.Preprint
Ciresa, R., Ciavaglia, E., Fiore, A., Stefani, F., Cominacini, M., Marchi, S. D., Girelli, D., & Carbonare, L. D. (2022) · Research Square · doi:10.21203/rs.3.rs-1374823/v1
Wen, H., He, Q., Jiao, Z., Xiang, X., & Yu, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1430743/v1
Konstantinides, S., Mavromanoli, A. C., & Hobohm, L. (2022) · Kardiologie up2date · doi:10.1055/a-1402-5103
The effect of contrast agents on the anticoagulant properties of oral factor Xa inhibitors
Cavlan, B., Arı, S., Arı, H., Çamcı, S., Melek, M., & Bozat, T. (2022) · Acta Radiologica · doi:10.1177/02841851221081474
Wen, H., He, Q., Jiao, Z., Xiang, X., & Yu, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1430743/v2
Grainger, B. T., Merriman, E., Royle, G., Eaddy, N., Ockelford, P., & Young, L. (2022) · Internal Medicine Journal · doi:10.1111/imj.15786
Proietti, M., & Ntaios, G. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1834-4923
Al-Khaiat, S. S., Mandalenakis, Z., & Dellborg, M. (2022) · Social Science Research Network · doi:10.2139/ssrn.4052368 · Cited by 1
Liu, X., Gu, Y., Zhang, Y., Shen, W., Gu, Z., Zhong, M.-K., Ding, H.-Y., & Ma, C.-L. (2022) · Research Square · doi:10.21203/rs.3.rs-1521812/v1
Pía-Morandeira, A., Cinza‐Sanjurjo, S., & Portela‐Romero, M. (2021) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2021.09.014
Wen, H., He, Q., Xiang, X., Jiao, Z., & Yu, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4133622
Ersoy, İ., & Ersoy, P. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.05.009
Complications in Device Therapy: Spectrum, Prevalence, and Management
Llewellyn, J., Garner, D., & Rao, A. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00563-0
Right selection of oral anticoagulation for stroke prevention in atrial fibrillation
Trailokya, A., Roy, D. G., Kerkar, P. G., Merchant, S. A., Sethi, R., Karnik, R. D., Manchanda, S. C., Shetty, S., Jadhav, U., & Vijan, V. (2022) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2022.029
Atrial Fibrillation is Not A Dead Horse
Fiori, P., Lia, A., Capaldo, G., Massarelli, M., Raffaele, G., Pelosi, C., Savino, P., Bellizzi, A., Giuseppe, B., Botticella, F., et al. (2022) · doi:10.33425/2639-944x.1257
Anticoagulación en pacientes con valvulopatía, más allá del ritmo
Bertomeu‐González, V., & Cordero, A. (2022) · REC CardioClinics · doi:10.1016/j.rccl.2022.07.007
Młyński, M., Sajek, M., Heleniak, Z., & Dębska-Ślizień, A. M. (2022) · Transplantology · doi:10.3390/transplantology3030022
5PSQ-011 Intravenous potassium chloride: hospital-wide evaluation and benefits of a video course
Roux, L., Lazzaro, E., Regnault, D., Poinsat, T., Merian-Brosse, L., & Lagrave, A. (2022) · Section 5: Patient safety and quality assurance · doi:10.1136/ejhpharm-2022-eahp.253
Az antikoaguláció szerepe a stroke-megelőzésben: a megfelelő NOAC-dózis választása
Oláh, L. (2022) · Cardiologia Hungarica · doi:10.26430/chungarica.2022.52.5.50
Wang, Z., Zhu, L., Yu, L., Chen, W., Chen, Y., Li, Q., Liu, Y., Jiao, S., Zhai, Z.-G., Zhao, L. R., et al. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.08.027
Diabetes und kardiovaskuläre Ereignisse
Darius, H. (2022) · Diabetes aktuell · doi:10.1055/a-1879-9266
Wang, J., Zhang, F., Liu, L., Pan, M.-M., Zhang, C., Chen, J., Bian, Y., Lin, H., & Gu, Z. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2310346
Oral anticoagulation – current knowlegde
Karaś, A., Kawałko, K., Bielewicz, K., Chmura, A., & Głodek, A. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.11.011
Was ist gesichert in der Therapie von Vorhofflimmern?
Liebe, V., Kruska, M., Dürschmied, D., & Akın, İ. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01418-5
Rivaroxaban bei tumorassoziierter venöser Thromboembolie
Bauersachs, R. M., Voigtländer, M., & Länger, F. P. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1933-1391
Guo, G., Liang, S., Guan, Z., & Zhu, K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1070806
Chen, L., Liang, T., Gao, H., & Zhang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2259868/v1
Can warfarin be replaced by non-vitamin K anticoagulants in prosthetic valves?
Abdelnabi, M. H., Benjanuwattra, J., Ahmed, A., & Almaghraby, A. M. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2152329
Hajj, W. E., & Nahon, S. (2022) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(22)47250-0
A pitvarfibrillációban szenvedő beteg antikoaguláns-terápiájának gyakorlata és kihívásai napjainkban
Kiss, D. Z., Kiss, B., & Zima, E. (2022) · Lege Artis Medicinae · doi:10.33616/lam.32.024a
Management of anticoagulant treatment in patients who need non-cardiac surgery
Rostagno, C. (2022) · Vessel Plus · doi:10.20517/2574-1209.2022.09
Anticoagulation for Patients Undergoing Implantation of a Cardiac Implantable Electronic Device
Llewellyn, J., Ezeonwumelu, C., Jackson, L., & Rao, A. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2022.0213
Adherencia és perzisztencia jelentősége az orális antikoaguláns kezelés során
Tornyos, D., Lukács, R. A., & Komócsi, A. (2022) · Cardiologia Hungarica · doi:10.26430/chungarica.2022.52.5.380
Direkt orális antikoaguláns kezelés billentyűhibák esetén: múlt-jelen-jövő
Kancz, S. (2022) · Cardiologia Hungarica · doi:10.26430/chungarica.2022.52.5.386
Edoxaban vs low molecular weight heparin in COVID-19 hospitalized patients with atrial fibrillationPreprint
Olivera, P. E., Escandón, C. A. V., Campoy, D., Flores, K., Canals, T., Johansson, E. A., Herranz, M. J., Martínez, L., Cerezo-Manchado, J. J., & Salinas, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2489367/v1
de la SEC, G. D. T. D. L. S. P. L. G. E. 2. S. L. E. C. Y. L. E. D. T. D. L. P. Q. S. S. A. C. N. C. Y. C. D. G. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2022.10.017
Variants of development and management of patients with persistent atrial fibrillation
Skybchyk, Y. V., Mikhaliev, К. О., & Zharinov, O. J. (2023) · Cardiac Surgery and Interventional Cardiology · doi:10.31928/2305-3127-2022.3-4.514
Ishiguchi, H., Okamura, T., & Yano, M. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad157
Prevention of thromboembolic complications in patients with atrial fibrillation and obesity
Kolasa, I., & Średniawa, B. (2023) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/158478
Acute arterial thrombosis in anticoagulated patient for acute pulmonary thromboembolism
Chelikikj, A., Poposka, L., Nastevska, E. G., Kandic, E., Bushljetikj, O., & ZİMBAKOV, Z. (2023) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.1176071
Herszényi, L., Aradi, D., Békássy, S., Járai, Z., Juhász, M. F., Kiss, R. G., Kolossváry, E., Nardai, S., Simonyi, G., Szőnyi, M., et al. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.2.150
Perioperative care about a patient with multimorbidity
Havel, E. (2023) · Vnitřní lékařství · doi:10.36290/vnl.2023.027
How to Anticoagulate Patients with Heart Failure and Cancer?
Renni, M. J. P., & Marinho, T. A. S. (2022) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20220093
García-Roy, Á., Sarsa-Gómez, A., Méndez-López, F., Urdin-Muñoz, B., & Sánchez-Calavera, M. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3002405/v1
杨, 富. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361309
Abelacimab: ¿llegó la nueva era de anticoagulantes?
Privitera, V. (2023) · Revista Hematología · doi:10.48057/hematologa.v27i1.525
Wójcik, S., Mocny‐Pachońska, K., Wójcik, M., & Morawiec, T. (2023) · Farmacja Polska · doi:10.32383/farmpol/169369
Jia, S., Song, Y., Yuan, D., Wang, P., Xu, J., Chen, Y., Zhang, C., Zhao, X., & Yuan, J. (2023) · medRxiv · doi:10.1101/2023.08.01.23293527
Krebstherapien und Herzrhythmusstörungen – worauf muss ich achten?
de Wall, C., Berliner, D., & Duncker, D. (2023) · Aktuelle Kardiologie · doi:10.1055/a-2055-5064
Atrial fibrillation after coronary bypass graft - what do we know now?
Misiło, A., Sosna, M., & Mordoń, K. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.43.01.002
Pauklin, P., Marandi, T., Kals, M., Ainla, T., Martinson, K., Eha, J., & Kampus, P. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03415-4
Perioperative Management of Oral Anticoagulation: A Real-World Observational Study
Sapio, P. L. (2021) · International Journal of Clinical Cardiology and Cardiovascular Interventions · doi:10.61148/2836-2837/ijccci/005
CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien
Heine, G. H. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00633-0
Rivaroxaban bei tumorassoziierter venöser Thromboembolie
Bauersachs, R. M., Voigtländer, M., & Länger, F. P. (2023) · TumorDiagnostik & Therapie · doi:10.1055/a-2132-9580
Fens, T., de Jong, L. A., Kappelhoff, B. S., Boersma, C., & Postma, M. J. (2023) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2023.2247719
Santamaría, A., Chen, C. Y.-H., Colonna, P., von Heymann, C., Saxena, M., Vanassche, T., Jin, J., & Unverdorben, M. (2023) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296231200223
Self-citationБакулина, Н. В., Викторович, Т. С., Григорьевна, А. А., & Ilyashevich, I. G. (2023) · Cardiac Arrhythmias · doi:10.17816/cardar321821
Köhler, C. U., Tittl, L., Hänsel, U., Hammermüller, E., Marten, S., Naue, C., Spindler, M., Stannek, L., Fache, K., & Beyer‐Westendorf, J. (2023) · TH Open · doi:10.1055/s-0043-1774304
Zhang, C., Gu, Z., Ma, E.-L., Liu, B.-L., Pan, M.-M., Wang, J., Wang, X., Wu, B., & Lin, H. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03570-9
PACIENTO PARUOŠIMAS NEŠIRDINEI OPERACIJAI, ESANT ŠIRDIES VOŽTUVO PAŽAIDAI
Aliulytė, R., Žemaitienė, L., Mizarienė, V., & Trepenaitis, D. (2023) · Health Sciences · doi:10.35988/sm-hs.2023.223
Tsai, C.-T., Liao, J., Chan, Y., Kuo, L., Liu, C., Lip, G. Y. H., & Chao, T. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4587158
Self-citationTanaka, T., Liu, X. E., Momozaki, N., Honda, E., Suehiro, E., & Matsuno, A. (2023) · JMA Journal · doi:10.31662/jmaj.2023-0087
Franchina, A. G., Rocchetti, M., Sala, E., Laricchia, A., Minardi, A., Spangaro, A., Guazzi, M., Lucreziotti, S., & Cereda, A. F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206559
Kwon, S., Lee, S., Choi, E., Lee, S., Jung, J., Han, K., Ahn, H., Oh, S., & Lip, G. Y. H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1208979
Self-citationSiegbahn, A., Svensson, P. J., Wallén, H., & Wallentin, L. C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192869227.003.0011
Agewall, S., Roldán, V., & Marín, F. R. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192869227.003.0027
Venous thromboembolism: prophylaxis and treatment
Er, C., Ageno, W., & Cohen, A. T. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192869227.003.0021
Benz, A. P., & Hohnloser, S. H. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192869227.003.0010
Management of patients treated with antithrombotic drugs undergoing surgery
Mæng, M., Kristensen, S. D., & Siller-Matula, J. M. (2023) · doi:10.1093/med/9780192869227.003.0025
Efficacy and safety of factor Xa inhibitors in low body weight patients
Tan, Y., Hubbard, C., Owens, H., Pitt, J., Giuliano, C. A., Haan, B. J., Breeden, T., Sirbu, D., Peña, K., Haddox, T., et al. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2888
Pokorney, S. D., & Granger, C. B. (2023) · Circulation · doi:10.1161/circulationaha.123.066600
Was ist gesichert in der Therapie des ischämischen Schlaganfalls?
Worthmann, H., Ernst, J., & Große, G. M. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01622-x
Metadata
- Authors
- Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., Sinnaeve, P., Vanassche, T., Potpara, T., Camm, A. J., Heidbüchel, H., reviewers, E., Lip, G. Y. H., Deneke, T., Dagres, N., Boriani, G., Chao, T.-F., Choi, E.-K., Hills, M. T., Santos, I. D. S., Lane, D. A., Atar, D., Joung, B., Cole, O. M., & Field, M.
- Affiliations
- University of Zurich (CH)
- Age-Related Health Care, Tallaght University Hospital / Department of Gerontology Trinity College , Dublin,
- Klinikum Braunschweig (DE)
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- Department of Neurology, Universitätsklinikum Würzburg , Würzburg,
- Uppsala University (SE)
- University Hospital Münster (DE)
- University of Murcia , Murcia,
- Middlesbrough ,
- KU Leuven (BE)
- University of Belgrade (RS)
- St George's, University of London (GB)
- University of Liverpool (GB)
- Rhön-Klinikum (DE)
- University of Modena and Reggio Emilia (IT)
- Seoul National University (KR)
- Universidade de São Paulo (BR)
- Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo , São Paulo,
- Oslo University Hospital (NO)
- Corresponding author
- Steffel, Jan
- ORCID
- Venue
- EP Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-25
- Volume
- 23
- Issue
- 10
- Pages
- 1612-1676
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- PMC
- PMC11636576
- OpenAlex
- W3159673032
- Cited by
- 1,132
- References
- 558
- Citations by year
- 2026: 148 · 2025: 179 · 2024: 228 · 2023: 269 · 2022: 224 · 2021: 83
- FWCI
- 134.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- EP Europace (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Lirias (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Bayer Pharma AG
- Bristol-Myers Squibb
- Pfizer Alliance
- Daiichi-Sankyo Europe GmbH
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- direct oral anticoagulants, atrial fibrillation, coronary artery disease, cardioversion, acute stroke, old age, frailty, stroke prevention
- MeSH terms
- Rivaroxaban, Dabigatran, Administration, Oral, Anticoagulants, Atrial Fibrillation, Humans, Pyridones, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
